AAAAAA

   
Results: 1-14 |
Results: 14
PHASE-I STUDY OF MITOXANTRONE PLUS ETOPOSIDE WITH MULTIDRUG BLOCKADE BY SDZ PSC-833 IN RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
Authors: KORNBLAU SM ESTEY E MADDEN T TRON HT ZHAO S CONSOLI U SNELL V SANCHEZWILLIAMS G KANTARJIAN H KEATING M NEWMAN RA ANDREEFF M
Citation: Sm. Kornblau et al., PHASE-I STUDY OF MITOXANTRONE PLUS ETOPOSIDE WITH MULTIDRUG BLOCKADE BY SDZ PSC-833 IN RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 15(5), 1997, pp. 1796-1802
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES - A FOLLOW-UP OF PATIENTS IN CLINICAL REMISSION
Authors: ENGEL H GOODACRE A KEYHANI A JIANG SW VAN NT KIMMEL M SANCHEZWILLIAMS G ANDREEFF M
Citation: H. Engel et al., MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES - A FOLLOW-UP OF PATIENTS IN CLINICAL REMISSION, British Journal of Haematology, 99(1), 1997, pp. 64-75
THE ROLE OF BCL-2 APOPTOSIS REGULATING GENES IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: ANDREEFF M ZHAO S KONOPLEVA M XIE Z ZHANG X SNELL V MCQUEEN T JIANG S KLICHE KO SCHENK T WEIDNER D ESTEY E THALL P SANCHEZWILLIAMS G KORNBLAU SM REED JC
Citation: M. Andreeff et al., THE ROLE OF BCL-2 APOPTOSIS REGULATING GENES IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 288-288
A FUNCTIONAL RECEPTOR IN AML - CORRELATION OF EXPRESSION WITH BLAST COUNT AND FAB M1
Authors: KONOPLEVA M MIKHAIL A ESTROV Z ZHAO S HARRIS D SANCHEZWILLIAMS G KORNBLAU S JUNG J KLICHE KO JIANG S PRZEPIORKA D SNODGRASS HR ESTEY E ANDREEFF M
Citation: M. Konopleva et al., A FUNCTIONAL RECEPTOR IN AML - CORRELATION OF EXPRESSION WITH BLAST COUNT AND FAB M1, Blood, 90(10), 1997, pp. 297-297
REGULATION OF APOPTOSIS IN AML, MDS AND NORMAL HEMATOPOIESIS
Authors: ANDREEFF M ZHAO S KLICHE O CONSOLI U LISOVSKY M SNELL V GOODACRE A MUNKER R ZHANG X SANCHEZWILLIAMS G DENG G DEISSEROTH A REED J ESTEY E
Citation: M. Andreeff et al., REGULATION OF APOPTOSIS IN AML, MDS AND NORMAL HEMATOPOIESIS, Experimental hematology, 24(9), 1996, pp. 568-568
REGULATION OF APOPTOSIS IN NORMAL HEMATOPOIESIS AND IN MYELOID LEUKEMIAS
Authors: ANDREEFF M ZHAO S KLICHE KO JIANG S CONSOLI U LISOVSKY M SNELL V ZHANG X SANCHEZWILLIAMS G REED J ESTEY E
Citation: M. Andreeff et al., REGULATION OF APOPTOSIS IN NORMAL HEMATOPOIESIS AND IN MYELOID LEUKEMIAS, Blood, 88(10), 1996, pp. 314-314
FLT3 LIGAND STIMULATES PROLIFERATION AND INHIBITS APOPTOSIS OF ACUTE MYELOID-LEUKEMIA CELLS - REGULATION OF BCL-2 AND BAX
Authors: LISOVSKY M ESTROV Z ZHANG X CONSOLI U SANCHEZWILLIAMS G SNELL V MUNKER R GOODACRE A SAVCHENKO V ANDREEFF M
Citation: M. Lisovsky et al., FLT3 LIGAND STIMULATES PROLIFERATION AND INHIBITS APOPTOSIS OF ACUTE MYELOID-LEUKEMIA CELLS - REGULATION OF BCL-2 AND BAX, Blood, 88(10), 1996, pp. 3987-3997
DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES IN CLINICAL REMISSION BY MOLECULAR CYTOGENETICS
Authors: ENGEL H GOOODACRE A KEYHANI A JIANG S VAN NT KIMMEL M SANCHEZWILLIAMS G ANDREEFF M
Citation: H. Engel et al., DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES IN CLINICAL REMISSION BY MOLECULAR CYTOGENETICS, Blood, 86(10), 1995, pp. 1059-1059
IN-VIVO REGULATION OF BCL-2 EXPRESSION IN AML PROGENITORS BY GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND DIRECT EVIDENCE FOR SELECTION OF BCL-2(++) CELLS BY INDUCTION CHEMOTHERAPY OF AML
Authors: ANDREEFF M JIANG S CONSOLI U BRANDES J SANCHEZWILLIAMS G DEISSEROTH A ESTEY E
Citation: M. Andreeff et al., IN-VIVO REGULATION OF BCL-2 EXPRESSION IN AML PROGENITORS BY GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND DIRECT EVIDENCE FOR SELECTION OF BCL-2(++) CELLS BY INDUCTION CHEMOTHERAPY OF AML, Blood, 86(10), 1995, pp. 2033-2033
P-GLYCOPROTEIN EXPRESSION CAN BE INDUCED IN AML BLASTS IN-VIVO FOLLOWING SHORT-TERM EXPOSURE TO CHEMOTHERAPY
Authors: CONSOLI U SNELL V ZHAO S SANCHEZWILLIAMS G ESTEY E ANDREEFF M
Citation: U. Consoli et al., P-GLYCOPROTEIN EXPRESSION CAN BE INDUCED IN AML BLASTS IN-VIVO FOLLOWING SHORT-TERM EXPOSURE TO CHEMOTHERAPY, Blood, 86(10), 1995, pp. 3002-3002
DETECTION OF HIGH PROLIFERATIVE MINIMAL RESIDUAL DISEASE IN ALL PATIENTS WITH AML AND MDS IN COMPLETE REMISSION WITH MONOSOMY-7 BY FACS FISH
Authors: ENGEL H DRACH J KEYHANI A JIANG S SANCHEZWILLIAMS G ANDREEFF M
Citation: H. Engel et al., DETECTION OF HIGH PROLIFERATIVE MINIMAL RESIDUAL DISEASE IN ALL PATIENTS WITH AML AND MDS IN COMPLETE REMISSION WITH MONOSOMY-7 BY FACS FISH, Blood, 84(10), 1994, pp. 10000300-10000300
DETECTION OF NORMAL-CELLS IN AN EARLY STEM-CELL COMPARTMENT IN MYELOID-LEUKEMIA BY MOLECULAR CYTOGENETICS
Authors: ENGEL H KLEINE HD JIANG S SANCHEZWILLIAMS G ANDREEFF M
Citation: H. Engel et al., DETECTION OF NORMAL-CELLS IN AN EARLY STEM-CELL COMPARTMENT IN MYELOID-LEUKEMIA BY MOLECULAR CYTOGENETICS, Blood, 84(10), 1994, pp. 10000421-10000421
FAILURE TO DETECT HIGH NUMBERS OF CIRCULATING APOPTOTIC CELLS IN LEUKEMIA PATIENTS UNDERGOING CYTOREDUCTIVE THERAPY
Authors: CONSOLI U KANTARJIAN H KLEINE HD ESTEY E SANCHEZWILLIAMS G ROBINSON JR ANDREEFF M
Citation: U. Consoli et al., FAILURE TO DETECT HIGH NUMBERS OF CIRCULATING APOPTOTIC CELLS IN LEUKEMIA PATIENTS UNDERGOING CYTOREDUCTIVE THERAPY, Blood, 84(10), 1994, pp. 10000617-10000617
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) - MOLECULAR CYTOGENETICS PREDICTS CLINICAL RELAPSE
Authors: ANDREEFF M LEAHY J GOODACRE A DRACH D SANCHEZWILLIAMS G PINKEL D DRACH J
Citation: M. Andreeff et al., MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) - MOLECULAR CYTOGENETICS PREDICTS CLINICAL RELAPSE, Blood, 82(10), 1993, pp. 10000036-10000036
Risultati: 1-14 |